Elite Pharmaceuticals (ELTP) EBITDA (2009 - 2026)
Elite Pharmaceuticals (ELTP) posted EBITDA of $10.31 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 19.7% from $8.61 million a year earlier and up 30.5% from the prior quarter.
Elite Pharmaceuticals (ELTP) EBITDA (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, EBITDA at Elite Pharmaceuticals was $38.16 million, down 12.9% year-over-year; for FY2026 (ended Mar 31, 2026), it was $50.66 million, up 138.0% from FY2025.
- Annual EBITDA has increased for three consecutive fiscal years, with a five-year compound annual growth rate of 71.5% (FY2021 to FY2026).
- In prior fiscal years, Elite Pharmaceuticals' EBITDA was $21.29 million in FY2025 (+75.1%), $12.16 million in FY2024 (+145.4%), $4.95 million in FY2023 (-21.1%) and $6.28 million in FY2022 (+83.7%).
- Quarterly EBITDA has run from a low of -$42,808 in fiscal Q4 2023 to a high of $22.09 million in fiscal Q1 2026 over five years.
- On a year-over-year basis, EBITDA increased in five of the last eight quarters, with growth averaging 140.3%.
- The strongest year-over-year quarter for EBITDA in the past five years was fiscal Q3 2026, with growth of 514.3%; the weakest was fiscal Q1 2027, with a decline of 64.3%.
- According to Business Quant data, EBITDA for the three prior fiscal quarters was $7.9 million (Q1 2027), $10.56 million (Q4 2026) and $9.4 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,293.04 Bn | 1,266.66 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 686.83 Bn | 606.69 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 525.76 Bn | 493.76 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 362.73 Bn | 325.68 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 313.98 Bn | 287.22 Bn | - | - |
| 6 | Astrazeneca | 287.17 Bn | 260.69 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 253.65 Bn | 205.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 210.81 Bn | 185.92 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 165.44 Bn | 112.80 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Elite Pharmaceuticals | 373.77 Mn | 247.18 Mn | 15.99 Mn | 10.31 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 10.31 Mn |
| Jun 30, 2026 | 7.90 Mn |
| Mar 31, 2026 | 10.56 Mn |
| Dec 31, 2025 | 9.40 Mn |
| Sep 30, 2025 | 8.61 Mn |
| Jun 30, 2025 | 22.09 Mn |
| Mar 31, 2025 | 11.56 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Sep 30, 2024 | 3.83 Mn |
| Jun 30, 2024 | 4.29 Mn |
| Mar 31, 2024 | 4.10 Mn |
| Dec 31, 2023 | 3.87 Mn |
| Sep 30, 2023 | 2.25 Mn |
| Jun 30, 2023 | 1.93 Mn |
| Mar 31, 2023 | -42,808.00 |
| Dec 31, 2022 | 2.28 Mn |
| Sep 30, 2022 | 1.40 Mn |
| Jun 30, 2022 | 1.32 Mn |
| Mar 31, 2022 | 1.15 Mn |
| Dec 31, 2021 | 2.13 Mn |
Elite Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();